The GLP-1 Effect: How Weight-Loss Drugs Are Changing the Business of Healthcare
America's GLP-1 boom is reshaping healthcare. SHARx co-founder Paul Pruitt explains who pays, why costs are surging, and what comes next.
America's GLP-1 boom is reshaping healthcare. SHARx co-founder Paul Pruitt explains who pays, why costs are surging, and what comes next.
Users are changing the ways they spend on food, clothes and health and beauty products, as well as how they eat out.
© Copyright 2026 Arizona Daily Star, PO Box 26887 Tucson, AZ 85726-6887
A Lee Enterprises, Incorporated newspaper. Majority shareholder: David Hoffmann, Hoffmann Media Group.
Get up-to-the-minute news sent straight to your device.